Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Molekule Group Inc (MKULQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Molekule historical data, for real-time data please try another search
0.02 +0.00    +0.00%
23/01 - Closed. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 0.00 - 0.02
Type:  Equity
Market:  United States
Molekule 0.02 +0.00 +0.00%

Molekule Company Profile

 
Read the Molekule Group Inc company profile to learn more about the business and the management team. View Molekule Group Inc facts about employee data, company products and services, and contact information.
IndustryProfessional & Commercial Services
SectorIndustrials
Employees

92

Equity Type

ORD

Molekule Group, Inc., an interior space air purification technology company, provides air purification solutions for hospitals and other healthcare facilities. The company offers interior air sterilization and disinfection products for the eradication of harmful airborne pathogens, including COVID-19. Its air hygiene product, Purgo (pure-go), a medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology applied in any indoor space, including in hospitals, offices, and elevators. The company’s Purgo products feature SteriDuct, a proprietary germicidal technology that work to equipment and devices to reduce the exposure of occupants of interior spaces to airborne particles and pathogens; Air Mini+, a direct-to-consumer air purifier, which features include a particle sensor, five fan speeds, and automatic fan speed adjustment through the product’s auto protect mode; Air Pro, a direct-to-consumer and business-to-business product for rooms of up to 1,000 square feet; and Air Pro Rx, a medical-grade purifier designed for traffic areas in healthcare facilities for rooms more than 600 square feet. It also offers PECO-HEPA Tri-Power filter; Molekule App, a mobile application that provides a 28 day look back of IAQ trends sensed by the Air Pro air purifier, breaking down pollutants detected, including VOCs, and pollutants that range from PM 1 to PM 10 in size; and Molekule Air Platform, a dashboard that allows data from multiple air purifiers and controls to be accessed in one interface. The company was formerly known as AeroClean Technologies, Inc. and changed its name to Molekule Group, Inc. in January 2023. Molekule Group, Inc. was founded in 2011 and is headquartered in Palm Beach Gardens, Florida. On October 3, 2023, Molekule Group, Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Florida.

Contact Information

Address 10455 Riverside Drive
Palm Beach Gardens, 33410
United States
Phone 833 652 5326
Fax -
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MKULQ Price Commentary

Write your thoughts about Molekule Group Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Klajdi Baha
Klajdi Baha Nov 03, 2023 19:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
We love the stock!!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email